Showing results (251-260 of 454) with videos related to

Sort By:
Pageof 46
Urologia Internationalis|August 5, 2006
Comparison of transperitoneal versus retroperitoneal approach in laparoscopic radical nephrectomy for renal cell carcinoma: a single-center experience of 63 casesNavid Berdjis, Oliver W Hakenberg, Steffen Leike, et al.
BMC Urology|April 1, 2014
A combined index to classify prognostic comorbidity in candidates for radical prostatectomyMichael Froehner, Anna-Elisa Kellner, Rainer Koch, et al.
European Urology|December 7, 2007
Advances in specific immunotherapy for prostate cancerAndrea Kiessling, Susanne Füssel, Rebekka Wehner, et al.
Food and Nutrition Bulletin|March 1, 2013
Lessons learned from national food fortification projects: experiences from Morocco, Uzbekistan, and VietnamJames P Wirth, Arnaud Laillou, Fabian Rohner, et al.
Experimental and Molecular Pathology|April 2, 2013
Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanismsAlbert Hagelgans, Mario Menschikowski, Susanne Fuessel, et al.
Urologia Internationalis|February 1, 2013
Systematic assessment of complications and outcome of radical cystectomy undertaken with curative intent in patients with comorbidity and over 75 years of ageVladimir Novotny, Oliver W Hakenberg, Michael Froehner, et al.
Virchows Archiv : an International Journal of Pathology|January 1, 1994
DNA-ploidy, G2M-fractions and prognosis of stages B and C prostate carcinomaJ G Müller, S Demel, M P Wirth, et al.
Urology|July 3, 2003
Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsyS Oehlschläger, S Albrecht, O W Hakenberg, et al.
Luminescence : the Journal of Biological and Chemical Luminescence|May 11, 2002
Measurement of free radicals and NO by chemiluminescence to identify the reperfusion injury in renal transplantationS Oehlschläger, S Albrecht, O W Hakenberg, et al.
Inflammation|December 23, 2011
Serum levels of secreted group IIA phospholipase A(2) in benign prostatic hyperplasia and prostate cancer: a biomarker for inflammation or neoplasia?Mario Menschikowski, Albert Hagelgans, Susanne Fuessel, et al.
Pageof 46